Financhill
Back

BioVie Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
36

BIVI
BioVie

Last Price:
2.80
Seasonality Move:
18.19%
Sell
19

NBY
NovaBay Pharmaceuticals

Last Price:
0.60
Seasonality Move:
1.46%
Sell
36
BioVie (BIVI) is a Sell

Is BioVie a Buy, Sell or Hold?

  • The current BioVie [BIVI] share price is $2.82. The Score for BIVI is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • BIVI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.61. The Score for NBY is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

BIVI Stock Price Chart

What is BioVie's stock price today?

  • The BioVie share price today is $2.82
    The current trend is moderately bearish and BIVI is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.

BIVI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.2 Buy
Relative Strength Index (14 RSI): 49.63 Sell
Chaikin Money Flow: -350637 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.61 - 3.25) Sell
Bollinger Bands (100): (1.87 - 3.79) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 39.49 Sell
Chaikin Money Flow: -71560 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.63 - 0.75) Sell
Bollinger Bands (100): (0.27 - 1.35) Sell

BIVI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.18 Sell
20-day SMA: 2.98 Sell
50-day SMA: 2.32 Buy
200-day SMA: 4.52 Sell
8-day EMA: 3.07 Sell
20-day EMA: 2.94 Sell
50-day EMA: 2.73 Buy
200-day EMA: 7.52 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.68 Sell
20-day SMA: 0.71 Sell
50-day SMA: 0.67 Sell
200-day SMA: 2.28 Sell
8-day EMA: 0.67 Sell
20-day EMA: 0.68 Sell
50-day EMA: 0.72 Sell
200-day EMA: 5.47 Sell

BioVie Earnings Growth & BIVI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.80 per share, and an increase next year of $7.39 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

BioVie Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):